StockData
PLRZNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Polyrizon Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026
$9.69−0.31 (-3.15%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
2.0
Dividend yield
–

Polyrizon Ltd. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-25.4%

Financial strength

Current ratio
36.37
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1877.2%

Valuation

P/E ratio
2.0
Price to sales
–
Price to book
–
Dividend yield
–